Patent Assignment
Reel/Frame 063371/0979
Release of Security Interest
Recorded: 2023-04-19
Pages: 5
Assignor
ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Executed: 2023-04-17
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD., DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Plasma Kallikrein Inhibitors and Methods of Use Thereof in Ocular Disorders
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Apr 18, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 063359/0174 →
Nunc Pro Tunc Assignment
Dec 29, 2025
From: BABU, YARLAGADDA
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073326/0400 →
Assignment of Assignor's Interest
Dec 29, 2025
From: KANSARA, VIRAL; MCELHENY, RICK
To: CLEARSIDE BIOMEDICAL, INC.
Reel/Frame 073326/0670 →
Assignment of Assignor's Interest
Dec 29, 2025
From: CLEARSIDE BIOMEDICAL, INC.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073326/0737 →
Security Interest
Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →